⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Guaifenesin-codeine
اکسپکتورانت کدئین (گایافنزین + کدئین)
🌬️ Respiratory SystemOpioid antitussive + expectorant
🤰 Pregnancy:Use with caution🤱 Breastfeeding:Use with caution 🇮🇷 Registered in Iran⛔ 1 contraindications 🇺🇸 OTC under FDA monograph M012
Market / country: 🇺🇸 USA
🧮 Dose calculator
Cough · Regimen source: FDA DSC 2018 · Safety Announcement
⛔ Doz does not calculate a dose for this combination product. Products differ in composition, and FDA limits codeine-containing cough medicines to adults 18 years and older. FDA DSC 2018 · Safety Announcement
🛡️ Safety & information
Contraindications
- ⛔ Codeine-containing cough and cold medicines are not recommended under 18 years: risk of slowed or difficult breathing, misuse, abuse, addiction, overdose and death. FDA DSC 2018 · Safety Announcement
Warnings
- • Cough due to a cold is self-limited and generally does not need to be treated. FDA DSC 2018 · Safety Announcement
Formulations
- Codeine 10 mg + guaifenesin 100 mg / 5 mL — solution 🇺🇸 USA FDA Guaif-Codeine OTC · Active ingredients
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Guaif-Codeine OTC · Drug Facts – Warnings
“If pregnant or breast-feeding, ask a health professional before use.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Guaif-Codeine OTC · Drug Facts – Warnings
“If pregnant or breast-feeding, ask a health professional before use.”
- 👶 ChildrenNo data
The source for this drug has no section for this group.
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)❌ None
- DailyMed (FDA label)FDA Guaif-Codeine OTC
- MedlinePlus (NIH)CodeineGuaifenesin
- WHO ATC/DDD❌ None
- Darooyab (Iran)Guaifenesin
🇮🇷 Registered in Iran Darooyab · G-2182/Guaifenesin
Dosage forms with Iranian generic codes, per Darooyab.
- 22092 · GUAIFENESIN 100MG SOFT GEL CAP · کپسول نرم گایافنزین ۱۰۰ میلیگرم
- 00614 · GUAIFENESIN 100MG/5ML 60ML SYRUP · شربت گایافنزین ۱۰۰ میلیگرم / ۵ میلیلیتر ۶۰ میلیلیتر
- 22093 · GUAIFENESIN 200MG SOFT GEL CAP · کپسول نرم گایافنزین ۲۰۰ میلیگرم
- 52664 · GUAIFENESIN SYRUP ORAL 100 mg/5mL 120 mL · شربت گایافنزین ۱۰۰ میلیگرم / ۵ میلیلیتر ۱۲۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Guaif-Codeine OTC · Active ingredientsFDA Guaif-Codeine OTC · Drug Facts – WarningsFDA Guaif-Codeine OTC · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline✅ PresentFDA DSC 2018 · Safety Announcement
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2182/Guaifenesin
- Clinical review⚠ Unverified